Don't try and move to CDG, there are redundancies planned there for early next year too.

2012 will be an interesting year at LSG. Polish off those resumes.

Quantalife will move to 925 or into multiple buildings in third quarter of 2012?

WHO?

And BW. How did he manage to survive so long

DT has left

Things are looking up for Bio Rad in the UK

I know for a fact the Bio-Rad "encourages" customers to nominate them.

<>

Clearly you don't understand the difference between Frost & Sullivan's practice of targeting companies for awards and then charging the winner for the right to mention their "award" and an independent survey of 6,000 scientific customer by Bioinfo who make the data available to all for further analysis.

Absolutely these things, as well as the Frost and Sullivan picks are total bogus, I don't even bother reading what and who was nominated. Some of these survey and market research firms are worthless, but if you are a desperate manager, they do offer some consolation, which makes you buy more bogus reports. This is not only true for Bio-Rad, but all vendors in this market. In the age of Yelp and online reviews, these things will thankfully disappear.

Anyone who has ever worked for or been a customer of Biorad (I have been both in my time) will realise what a nonsense these nominations are.

The purchase of Quanta Life was a bold move and shows that they are capable of innovative business deals. If Quanta Life's digital PCR becomes the new standard for qPCR we will look back on this purchase as brilliant.

Quanta Life what?

Quanta Life

"Unimpressed by this and still think that Bio-Rad lacks a culture of quality and innovation. Not all that hard to get nominated and considering the process, it is pretty easy for companies to game the system to get nominated."

I don't believe there were any award categories for quality or innovation so that's a separate issue (and one that I don't entirely disagree with). But the organizers been very transparent about the process:

http://www.lifescienceindustryawards.com/2011/methodology.html

and it's hard to see how companies could "game the system" when something like 6500 individual scientists participated. They've also been very open in past years in releasing the survey data for anyone to review which we've found very helpful.

RE: "Bio-Rad's baser qualities aside, it looks like their customers like the equipment. 21 nominations!"

Sure!
For example, SELDI as a protein analysis instrument get nominations!
It really the case "looks like" customers like products, but in reality product so sucks that it will be discontinued soon.

The only benefit for this kind of survey is to provide top management excuse to award themselves more bonus.

RE: "Bio-Rad's baser qualities aside, it looks like their customers like the equipment. 21 nominations!"

Unimpressed by this and still think that Bio-Rad lacks a culture of quality and innovation. Not all that hard to get nominated and considering the process, it is pretty easy for companies to game the system to get nominated. Especially those companies that conduct business with Bioinformatics or other sponsors such as the Chempetitive Group.

"Great news"

What a prick.

Great news!!! V

Bio-Rad's baser qualities aside, it looks like their customers like the equipment. 21 nominations! http://www.lifescienceindustryawards.com/2011/categories.html

Another MJ

Biorad don't care about your business methods or your staff they just want your customers. If they can take the sales and fire all the staff then that is the preferred option.

Based upon BR tradition, it might take about 3 years for quant-life to disappear totally. But this time, LSG might disappear together since they can't afford 100 million dollar loss this time.

Does anyone have a clue why Luminex technology in the Bio-plex 2200 analyzers is considered as an inferior technology? is it a Luminex or a Bio-Rad fuck up?

Better start looking for a new job now. Once Bio-rad buy you over it's the beginning of the end.

WOW!!!!

QuantaLifers should get ready to be forced to move to Hercules, have their innovation stifled, and start looking for another job.

FOR IMMEDIATE RELEASE

Bio-Rad Acquires QuantaLife and Digital PCR Technology

Hercules, CA – October 5, 2011 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a
multinational manufacturer and distributor of life science research and clinical
diagnostics products, announced today that it has purchased QuantaLife, Inc. for $162
million in cash plus potential future milestone payments.
QuantaLife has developed an innovative digital PCR (Polymerase Chain Reaction)
system that provides quantification of target molecules with unprecedented precision
and sensitivity. This next generation PCR technology builds on the well established
method of amplifying DNA that is used in research laboratories around the world. Digital
PCR provides researchers with a new tool for the detection of rare mutations including
distinguishing rare sequences in tumors, precise measurement of copy number
variation, and absolute quantification of gene expression.
“We are impressed with QuantaLife’s digital PCR technology and believe it will
complement Bio-Rad’s existing amplification business,” said Norman Schwartz,
Bio-Rad President and CEO. “This elegant solution expands the current state of the art
methods of quantitative PCR (qPCR), and we look forward to its adoption in life science
research.”
About QuantaLife
Based in Pleasanton, California, QuantaLife is a privately-held life sciences company
that provides advanced genetic analysis systems for research. QuantaLife has
commercialized the Droplet Digital™ (ddPCR) system, the most accurate
genetic analysis platform available today. The system is the first cost-effective, highresolution
platform available for the validation of next-generation sequencing
discoveries. It is easy to use, easy to automate, and easy to integrate into existing
workflows in both life science and clinical research labs. With the ddPCR system,
researchers can explore complex genetic landscapes in high-definition, discover new
disease associations, and define a new category of improved molecular diagnostic
tests.

"In a word: Sweatshop. How hard is it to make and sell a green polystyrene box with electrodes on either end? Ok, we'll give you that. Yes, you do that well! lol"

It sounds that you are not working for BR.
BR tried hard to outsource just the molding of the green box oversea, it took millions dollar and over 3 years. Even now, BR can only make the product at Hercules.

In short, incompetence makes BR outdated.

In a word: Sweatshop. How hard is it to make and sell a green polystyrene box with electrodes on either end? Ok, we'll give you that. Yes, you do that well! lol

what's happening in BR Canada? Is David G still there?

"Is it to be an LSG or CDG acqisition"

I guess BioRad will buy parts of BC from Danaher

You mean that LSG will be acquired?

Do tell about the big acquisition. You can't just leave us hanging without some hints.
But then, if it goes the way of other acquisitions, whatever is acquired will be dead within two years.

Agreed if past performance is an indicator. Is it to be an LSG or CDG acqisition

Perhaps they are going to acquire some business skills?

Do tell about the big acquisition. You can't just leave us hanging without some hints.
But then, if it goes the way of other acquisitions, whatever is acquired will be dead within two years.

Big Aquisition Coming

""LL and HG from Ciphergen"
It seems HG mentioned here is the manufacturing manager at Nobel.
LL is a manager at LSD R&D.
"

LL is only capable of echoing. After RP gone, he even can't echoing anymore.

Tech associate I is hourly and chemist I is salary. Used to be a tech was entry level out of high school or limited experience and a chemist had limited experience out of college.

Have they found a replacement for DT in the UK yet??

Yes

Technical associate I versus chemist I

What is the difference?

"LL and HG from Ciphergen"
It seems HG mentioned here is the manufacturing manager at Nobel.
LL is a manager at LSD R&D.

Have they found a replacement for DT in the UK yet??

LL and HG from Ciphergen

Are they still here. What is their positions now

"The problem is that when BR buys a company, they quickly try to make the company follow the "Bio-Rad way" of doing things. If BR would have just left the acquired companys alone so that these companys could have continue to operate relatively independently, it is very likely that BR's acquisitions would have been successful."

So BR way is almost bullet-proof way to make a company to fail?

It's worth to note that BR also had a tendency to promote folks from acquried companies who "fit BR culture".
For example, LL and HG from Ciphergen; who are main contributors for the former company's failure.

You mean Diamed.

"BR will collapse for sure.
They lost tons of money on purchasing companies. Here are a a few names: 1) MJ 2) Ciphergen 3)Biomed. All of them turned out to be total failure."

The problem is that when BR buys a company, they quickly try to make the company follow the "Bio-Rad way" of doing things. If BR would have just left the acquired companys alone so that these companys could have continue to operate relatively independently, it is very likely that BR's acquisitions would have been successful.

BR will collapse for sure.
They lost tons of money on purchasing companies. Here are a a few names: 1) MJ 2) Ciphergen 3)Biomed. All of them turned out to be total failure.

CDG is no better. That's why LOTS of people leave them.

Total mess
That's why I left them.